論文 - 清井 仁
-
A Tet-On Inducible System for Controlling CD19-Chimeric Antigen Receptor Expression upon Drug Administration. 査読有り
Sakemura R, Terakura S, Watanabe K, Julamanee J, Takagi E, Miyao K, Koyama D, Goto T, Hanajiri R, Nishida T, Murata M, Kiyoi H.
Cancer Immunol Res. 4 巻 ( 8 ) 頁： 658-68 2016年8月
-
SPIB is a novel prognostic factor in diffuse large B-cell lymphoma that mediates apoptosis via the PI3K-AKT pathway. 査読有り
Takagi Y, Shimada K, Shimada S, Sakamoto A, Naoe T, Nakamura S, Hayakawa F, Tomita A, Kiyoi H.
Cancer Sci. 頁： [Epub ahead of print] 2016年6月
-
PAX5 tyrosine phosphorylation by SYK co-operatively functions with its serine phosphorylation to cancel the PAX5-dependent repression of BLIMP1: A mechanism for antigen-triggered plasma cell differentiation. 査読有り
Inagaki Y, Hayakawa F, Hirano D, Kojima Y, Morishita T, Yasuda T, Naoe T, Kiyoi H.
Biochem Biophys Res Commun. 475 巻 ( 2 ) 頁： 176-81 2016年6月
-
Peripheral blood cell-free DNA is an alternative tumor DNA source reflecting disease status in myelodysplastic syndromes. 査読有り
Suzuki Y, Tomita A, Nakamura F, Iriyama C, Shirahata-Adachi M, Shimada K, Akashi A, Ishikawa Y, Kaneda N, Kiyoi H.
Cancer Sci. 頁： [Epub ahead of print] 2016年6月
-
Co-expression of wild-type FLT3 attenuates the inhibitory effect of FLT3 inhibitor on FLT3 mutated leukemia cells. 査読有り
Chen F, Ishikawa Y, Akashi A, Naoe T, Kiyoi H.
Oncotarget. 頁： [Epub ahead of print] 2016年6月
-
Live-cell single-molecule imaging of the cytokine receptor MPL for analysis of dynamic dimerization. 査読有り
Sakamoto A, Tsukamoto T, Furutani Y, Sudo Y, Shimada K, Tomita A, Kiyoi H, Kato T, Funatsu T.
J Mol Cell Biol. 頁： [Epub ahead of print] 2016年6月
-
BCR-ABL-specific CD4+ T-helper cells promote the priming of antigen-specific cytotoxic T cells via dendritic cells. 査読有り
Ueda N, Zhang R, Tatsumi M, Liu TY, Kitayama S, Yasui Y, Sugai S, Iwama T, Senju S, Okada S, Nakatsura T, Kuzushima K, Kiyoi H, Naoe T, Kaneko S, Uemura Y.
Cell Mol Immunol 頁： [Epub ahead of print] 2016年5月
-
Identification of Meflin as a Potential Marker for Mesenchymal Stromal Cells. 査読有り
Maeda K, Enomoto A, Hara A, Asai N, Kobayashi T, Horinouchi A, Maruyama S, Ishikawa Y, Nishiyama T, Kiyoi H, Kato T, Ando K, Weng L, Mii S, Asai M, Mizutani Y, Watanabe O, Hirooka Y, Goto H, Takahashi M.
Sci Rep. 6 巻 頁： 22288 2016年2月
-
B Cell Linker Protein (BLNK) Is a Selective Target of Repression by PAX5-PML Protein in the Differentiation Block That Leads to the Development of Acute Lymphoblastic Leukemia. 査読有り
Imoto N, Hayakawa F, Kurahashi S, Morishita T, Kojima Y, Yasuda T, Sugimoto K, Tsuzuki S, Naoe T, Kiyoi H.
J Biol Chem. 291 巻 ( 9 ) 頁： 4723-31 2016年2月
-
The first case of antithrombin-resistant prothrombin Belgrade mutation in Japanese. 査読有り
Kishimoto M, Suzuki N, Murata M, Ogawa M, Kanematsu T, Takagi A, Kiyoi H, Kojima T, Matsushita T.
Ann Hematol. 95 巻 ( 3 ) 頁： 541-2 2016年2月
-
A case of MYH9 disorders caused by a novel mutation (p.K74E). 査読有り
Kanematsu T, Suzuki N, Yoshida T, Kishimoto M, Aoki T, Ogawa M, Kagami Y, Kiyoi H, Matsushita T, Kunishima S.
Ann Hematol 95 巻 ( 1 ) 頁： 161-3 2016年1月
-
Clinical usefulness of WT1 mRNA expression in bone marrow detected by a new WT1 mRNA assay kit for monitoring acute myeloid leukemia: a comparison with expression of WT1 mRNA in peripheral blood. 査読有り
Kitamura K, Nishiyama T, Ishiyama K, Miyawaki S, Miyazaki K, Suzuki K, Masaie H, Okada M, Ogawa H, Imai K, Kiyoi H, Naoe T, Yokoyama Y, Chiba S, Hata T, Miyazaki Y, Hatta Y, Takeuchi J, Nannya Y, Kurokawa M, Ueda Y, Koga D, Sugiyama H, Takaku F.
Int J Hematol. 103 巻 ( 1 ) 頁： 53-62 2016年1月
-
High-dose chemotherapy followed by autologous stem cell transplantation for relapsed/refractory primary mediastinal large B-cell lymphoma. 査読有り
Aoki T, Shimada K, Suzuki R, Izutsu K, Tomita A, Maeda Y, Takizawa J, Mitani K, Igarashi T, Sakai K, Miyazaki K, Mihara K, Ohmachi K, Nakamura N, Takasaki H, Kiyoi H, Nakamura S, Kinoshita T, Ogura M.
Blood Cancer J. 5 巻 頁： e372 2015年12月
-
Overview: A New Era of Cancer Genome in Myeloid Malignancies. 招待有り 査読有り
Kiyoi H.
Oncology. 89 巻 ( Suppl 1 ) 頁： 1-3 2015年11月
-
Phase I trial of volasertib, a Polo-like kinase inhibitor, in Japanese patients with acute myeloid leukemia. 査読有り
Kobayashi Y, Yamauchi T, Kiyoi H, Sakura T, Hata T, Ando K, Watabe A, Harada A, Taube T, Miyazaki Y, Naoe T.
Cancer Sci. 106 巻 ( 11 ) 頁： 1590-5 2015年11月
-
Target Antigen Density Governs the Efficacy of Anti-CD20-CD28-CD3 ζ Chimeric Antigen Receptor-Modified Effector CD8+ T Cells. 査読有り
Watanabe K, Terakura S, Martens AC, van Meerten T, Uchiyama S, Imai M, Sakemura R, Goto T, Hanajiri R, Imahashi N, Shimada K, Tomita A, Kiyoi H, Nishida T, Naoe T, Murata M.
J Immunol. 194 巻 頁： 911-20 2015年
-
Discovery of a drug targeting microenvironmental support for lymphoma cells by screening using patient-derived xenograft cells. 査読有り
Sugimoto K, Hayakawa F, Shimada S, Morishita T, Shimada K, Katakai T, Tomita A, Kiyoi H, Naoe T.
Sci Rep. 5 巻 頁： 13054 2015年
-
Integration of humoral and cellular HLA-specific immune responses in cord blood allograft rejection. 査読有り
Hanajiri R, Murata M, Sugimoto K, Murase M, Sakemura R, Goto T, Watanabe K, Imahashi N, Terakura S, Ohashi H, Akatsuka Y, Kurahashi S, Miyamura K, Kiyoi H, Nishida T, Naoe T.
Bone Marrow Transplant 50 巻 頁： 1187-94 2015年
-
FLT3 Inhibitors: Recent Advances And Problems For Clinical Application. 招待有り 査読有り
Kiyoi H
Nagoya J Med Sci 77 巻 頁： 7-17 2015年
-
Chimerism status after unrelated donor bone marrow transplantation with fludarabine-melphalan conditioning is affected by the melphalan dose and is predictive of relapse. 査読有り
Imahashi N, Ohashi H, Terakura S, Miyao K, Sakemura R, Kato T, Sawa M, Yokohata E, Kurahashi S, Ozawa Y, Nishida T, Kiyoi H, Watamoto K, Kohno A, Kasai M, Kato C, Iida H, Naoe T, Miyamura K, Murata M; for the Nagoya Blood and Marrow Transplantation Group.
Ann Hematol 94 巻 頁： 1139-48 2015年